Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development – a Randomized Clinical Trial
Condition(s):Uncomplicated Plasmodium Falciparum MalariaLast Updated:March 13, 2023Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Uncomplicated Plasmodium Falciparum MalariaLast Updated:March 13, 2023Not yet recruiting
Condition(s):Vivax Malaria; G6PD DeficiencyLast Updated:July 11, 2023Recruiting
Condition(s):MalariaLast Updated:March 6, 2024Not yet recruiting
Condition(s):Malaria; Malaria,Falciparum; Protozoan Infections; Parasitic Disease; Infections; Vector Borne DiseasesLast Updated:November 21, 2023Recruiting
Condition(s):Lung Cancer, Nonsmall CellLast Updated:June 22, 2023Recruiting
Condition(s):MalariaLast Updated:March 5, 2024Recruiting
Condition(s):Plasmodium Vivax MalariaLast Updated:February 6, 2024Not yet recruiting
Condition(s):Plasmodium Falciparum Malaria (Uncomplicated)Last Updated:March 27, 2024Recruiting
Condition(s):Advanced CancersLast Updated:February 20, 2024Recruiting
Condition(s):Advanced Breast Cancer; Advanced Liver CancerLast Updated:February 20, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.